股票行情快报：开立医疗（300633）12月4日主力资金净买入457.28万元

Core Viewpoint - The stock of Kailing Medical (300633) has shown a decline in price and mixed fund flow data, indicating potential challenges in market sentiment and performance metrics [1][2]. Financial Performance - As of December 4, 2025, Kailing Medical's stock closed at 26.73 yuan, down by 1.0% with a trading volume of 24,900 hands and a transaction value of 66.73 million yuan [1]. - In the third quarter of 2025, the company reported a main revenue of 4.95 billion yuan, an increase of 28.42% year-on-year, but a net profit of -135.92 million yuan, reflecting a 78.05% increase in losses compared to the previous year [3]. - For the first three quarters of 2025, the company achieved a main revenue of 14.59 billion yuan, up by 4.37% year-on-year, while the net profit decreased by 69.25% to 33.51 million yuan [3]. Market Position and Ratios - Kailing Medical's total market value is 11.566 billion yuan, slightly above the industry average of 10.958 billion yuan, ranking 27th out of 124 in the medical device industry [3]. - The company has a price-to-earnings ratio (P/E) of 258.86, significantly higher than the industry average of 60.57, ranking 87th out of 124 [3]. - The gross margin stands at 60.36%, which is above the industry average of 51.22%, ranking 50th out of 124 [3]. Fund Flow Analysis - On December 4, 2025, the net inflow of main funds was 4.5728 million yuan, accounting for 6.85% of the total transaction value, while retail investors experienced a net outflow of 2.4947 million yuan, representing 3.74% of the total [1][2]. - Over the past five days, the stock has seen fluctuating fund flows, with the highest net inflow of main funds recorded on December 2, 2025, at 3.3875 million yuan [2]. Analyst Ratings - In the last 90 days, 15 institutions have rated Kailing Medical, with 10 buy ratings and 5 hold ratings, indicating a generally positive outlook among analysts [4]. - The average target price set by institutions over the past 90 days is 41.28 yuan, suggesting potential upside from the current trading price [4].